Evidence map›Paper›PMID 39910105›Full record

ArticleScientific reports2025

Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.

Diego Alem, César X García-Laviña, Francisco Garagorry, Dardo Centurión, Joaquina Farias, Hany Pazos-Espinosa, María Noel Cuitiño-Mendiberry, Carolina Villadóniga, Susana Castro-Sowinski, Martín Fló and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Diego Alem *Departamento de Genética, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay. alemdiego@gmail.com.
César X García-LaviñaSección Bioquímica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
Francisco GaragorryCátedra de Anatomía Patológica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Dardo CenturiónCátedra de Anatomía Patológica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Joaquina FariasEspacio de Biología Vegetal del Noreste, CENUR Noreste, Universidad de la República, Tacuarembó, Uruguay.
Hany Pazos-EspinosaDepartamento de Genética, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay.
María Noel Cuitiño-MendiberryBioterio de roedores, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay.
Carolina VilladónigaLaboratorio de Biocatalizadores y sus Aplicaciones, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
Susana Castro-SowinskiDepartamento de Genética, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay.
Martín FlóLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Federico CarriónLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Brenda IglesiasResearch Technologies, Research Operations and Externalization, GSK-R&D, Boston, USA.
Kevin MadaussResearch Technologies, Research Operations and Externalization, GSK-R&D, Boston, USA.
Lucía Canclini *Departamento de Genética, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay. lcanclini@iibce.edu.uy.

Funding

Agencia Nacional de Investigación e Innovación FSGSK_1_2020_1_165443Agencia Nacional de Investigación y Desarrollo SNI
6 · The paper itself

Abstract

Despite the current diagnostic and therapeutic approaches to bladder cancer being widely accepted, there have been few significant advancements in this field over the past decades. This underscores the necessity for a paradigm shift in the approach to bladder cancer. The role of amyloids in cancer remains unclear despite their identification in several other pathologies. In this study, we present evidence of amyloids in bladder cancer, both in vitro and in vivo. In a murine model of bladder cancer, a positive correlation was observed between amyloids and tumor stage, indicating an association between amyloids and bladder cancer progression. Subsequently, the amyloid proteome of the RT4 non-invasive and HT1197 invasive bladder cancer cell lines was identified and included oncogenes, tumor suppressors, and highly expressed cancer-related proteins. It is proposed that amyloids function as structures that sequester key proteins. Therefore, amyloids should be considered in the study and diagnosis of bladder cancer.

Indexed as

AmyloidUrinary Bladder NeoplasmsAnimalsCell Line, TumorFemaleHumansMiceNeoplasm StagingProteomeAmyloidProteome

Identifiers

PMID39910105
PMCPMC11799152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.